Skip to: Content
Skip to: Site Navigation
Skip to: Search
SATURDAY, NOVEMBER 21, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Roche

Roche stories: 6 news summaries
H1N1 OUTBREAK

 Feds Release Last of 
 Kids Tamiflu Stockpile 

Swine flu has killed at least 114 US children and teens

Oct 30, 09 10:42 PM CDT
(Newser) - With the swine flu outbreak taking an enormous, and sometimes fatal, toll on American kids, the Centers for Disease Control today released the last of its stockpiles of the children’s version of flu drug Tamiflu. Some 114 youngsters have been reported killed by the virus, and the actual number... More »

MORE ABOUT:
Centers for Disease Control and Prevention • Tamiflu • Roche • US stockpiles • swine flu • H1N1 virus • women's issues • flu season

h1n1 outbreak

Fears Trigger Rush on
Liquid Tamiflu for Kids

Sporadic shortages reported around the country

Oct 28, 09 6:06 PM CDT
(Newser) - Parents are scrambling in parts of the country to find liquid Tamiflu for their kids. It's selling out so quickly in drug stores that federal officials have given pharmacists a back-up plan: They can mix syrup with the powdery adult capsules—the precise ratio is determined by a child's weight—... More »

MORE ABOUT:
medicine • flu shot • Tamiflu • Roche • swine flu • H1N1 virus

MARKETS

 Swine Flu Sends 
 Travel Stocks Falling 

Airlines decline while drugmakers advance; Mexican peso tumbles

Apr 27, 09 6:39 AM CDT
(Newser) - Stocks declined worldwide today, with travel companies leading losses as investors gave their first reaction to the outbreak of swine flu. Airlines took a pummeling—Lufthansa fell more than 12%, British Airways 8.7%—and tour operators like Carnival also suffered sharp drops. But pharmaceutical companies did well: drugmaker Roche,... More »

MORE ABOUT:
Mexico • British Airways • markets • Lufthansa • European markets • outbreak • influenza • Tamiflu • Roche • foreign currency • swine flu • Mexican peso

Colon Cancer Drug Flunks Important Test

Avastin's effects on early-stage disease don't meet expectations

Apr 22, 09 8:07 AM CDT
(Newser) - Clinical trials to determine the drug Avastin’s effects on early-stage colon cancer were a big disappointment for drug firm Genentech, the New York Times reports. The drug, which is typically used in late-stage cancer, didn’t significantly cut the recurrence rate among 2,700 subjects in the early stages,... More »

MORE ABOUT:
study • drug companies • cancer research • cancer treatment • Genentech • Roche • Avastin • clinical trials

(Newser) - Swiss drug giant Roche has succeeded in its quest to own biotech firm Genentech outright, and will purchase the 44% of shares it does not already own for $95 each, the San Francisco Chronicle reports today. The $46.8 billion deal comes after months of haggling, wherein Roche offered as... More »

MORE ABOUT:
California • San Francisco • pharmaceutical companies • hostile takeover • mergers and acquisitions • biotechnology • Genentech • Roche • biotech companies

Tamiflu Will Carry Stronger Warning Labels

Maker will beef up language on possible psychiatric side effects

Nov 28, 07 4:51 PM CST
(Newser) - The maker of flu drug Tamiflu said today it will accept recommendations by a government panel that it revise printed warnings about the medication's side effects. Labels already warn of possible psychiatric reactions, but the panel recommended noting that some people have died, the AP reports. Drugmaker Roche says flu... More »

MORE ABOUT:
FDA • GlaxoSmithKline • Tamiflu • Relenza • flu medications • Roche

6 Stories


from our news partners